TUSC1 and chronic myelogenous leukemia, BCR-ABL1 positive: Downregulation of all three diagnostic ARGs was observed in CML samples in the GSE144119 cohort (Figure 7A), as well as in our clinically independent cohort (Figure 7D), in which the difference in TUSC1 expression between CML and normal samples did not show statistical significance, possibly due to the small sample size.